Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for producing Huonaoxin Chinese medicinal capsule used for traeting cardi-cerebral vascular disease

A technology of cardiovascular and cerebrovascular diseases and traditional Chinese medicine capsules, which is applied to cardiovascular system diseases, medical formulas, drug combinations, etc., can solve the problems of poor treatment effect, neglect of early prevention, high price, etc., and achieve high cure rate, less recurrence and quick effect Effect

Inactive Publication Date: 2002-12-18
赵广钧
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] There have been a variety of traditional Chinese medicines for the treatment of the above diseases before, but most of the prescriptions are administered for the symptoms after the onset and do not involve the pathogenesis. Therefore, early prevention is neglected, so that the occurrence of cardiovascular and cerebrovascular diseases cannot be controlled in the early stage. The effect is poor, the price is relatively high, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0024] Embodiment: Take the production of 1200g dry powder, 0.3g per capsule, 4000 Huonaoxin capsules in total as an example.

[0025] Prescription of the present invention is as follows:

[0026] Codonopsis 28g Purple Salvia 48g Turmeric 7g

[0027] Shouwu 16g, Caulis Spatholobus 21g, peach kernel 14g

[0028] The formula weight of astragalus above 42g is the dry powder weight of the final active ingredient extracted.

[0029] Chuanxiong 300g Gastrodia elata 250g Centipede 100g

[0030] Pueraria 300g, borneol 50g, bezoar 30g

[0031] The production process is as follows: first take

[0032] Codonopsis 28g×14.3=400g (7% extraction rate)

[0033] Danshen 48g×16.7=800g (extraction rate 6%)

[0034] Curcuma 7g×14.3=100g (extraction rate is 7%)

[0035] Shouwu 16g×12.5=200g (extraction rate 8%)

[0036] Spatholobus 21g×14.3=300g (extraction rate 7%)

[0037] Peach kernel 14g×14.3=200g (7% extraction rate)

[0038] Astragalus 42g×14.3=600g (7% extraction rate)

[0039] P...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The Huonaoxin Chinese medicine capsule for curing cardio-cerebral vascular disease is made of 13 Chinese medicinal materials of cononopsis root, salvia root, curcuma tuber, prepared flowery knotweed root, millettia root and stem and others through the processes of extracting effective components, drying to obtain dried powders, mixing them and capsulizing. As compared with existent medicine it ishigh in cure rate, short in course of treatment and has no side effect, etc.

Description

technical field [0001] The invention discloses a production method of Huoxinxin medicinal capsules for treating cardiovascular and cerebrovascular diseases. Background technique [0002] With the continuous development of modern civilization, coronary heart disease, angina pectoris, cerebral insufficiency, hyperlipidemia and other types of diseases have become common and frequently-occurring diseases, threatening human life and health increasingly seriously. [0003] There have been a variety of traditional Chinese medicines for the treatment of the above diseases before, but most of the prescriptions are administered for the symptoms after the onset and do not involve the pathogenesis. Therefore, early prevention is neglected, so that the occurrence of cardiovascular and cerebrovascular diseases cannot be controlled in the early stage. The effect is poor, the price is relatively high and other shortcomings. Contents of the invention [0004] The purpose of the present in...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61P9/10
Inventor 赵广钧
Owner 赵广钧